ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED SUBMUCOSAL ADENOCARCINOMA IN BARRETT’S ESOPHAGUS: EARLY RESULTS OF AN ONGOING PROSPECTIVE, INTERNATIONAL, MULTICENTER COHORT REGISTRY (PREFER TRIAL)

Man Wai Chan  ¹     Esther A. Nieuwenhuis  ¹     M. Jansen  ²     Kamar Belghazi  ²     W. B. Nagengast  ³     Jessie Westerhof  ³     Arjun D. Koch  ⁴     Manon C.W. Spaander  ⁴     Raf Bisschops  ⁵     G. De Hertogh  ⁵     Michael John Bourke  ⁶     Horst Neuhaus  ⁷     Bas L.A.M. Weusten  ⁸     Alaa Alkhalaf  ⁹     Oliver Pech  ¹⁰     Christoph Schlag  ¹¹     Stefan Seewald  ¹²     Martin Houben  ¹³     Erik J. Schoon  ¹⁴     Emmanuel Coron  ¹⁵     Rehan Jamil Haidry  ¹⁶     Helmut Messmann  ¹⁷     Sybren L. Meijer  ¹⁷     Jacques J. Bergman  ¹⁷     Roos E. Pouw  ^17    
1 Amsterdam University Medical Centers, Amsterdam, Netherlands
² University College London Hospital NHS Trust, London, United Kingdom
³ University Medical Center Groningen, Groningen, Netherlands
⁴ Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands
⁵ Katholieke Universiteit Leuven, Leuven, Belgium
⁶ Westmead Hospital Sydney, Westmead, NSW, Australia
⁷ Evangelisches Krankenhaus Düsseldorf, Düsseldorf, Germany
⁸ Sint Antonius Hospital, Nieuwegein, Netherlands
⁹ Alkhalaf, Zwolle, Netherlands
¹⁰ Krankenhaus Barmherzige Brüder Klinik für Gastroenterologie und Interventionelle Endoskopie, Regensburg, Germany
¹¹ Technical University of Munich, II, München, Germany
¹² GastroZentrum Hirslanden, Zurich, Switzerland
¹³ Haga Teaching Hospital, The Hague, Netherlands
¹⁴ Catharina Hospital, Eindhoven, Netherlands
¹⁵ Nantes University Hospital, Nantes, France
¹⁶ University College Hospital NHS Trust, London, United Kingdom
¹⁷ Uniklinik Augsburg, Augsburg, Germany

Session
Reflux disease (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)